Nuveen Asset Management, LLC Icosavax, Inc. Transaction History

Nuveen Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$5.95 - $15.79 $58,565 - $155,420	9,843 Added 11.03%	99,101 $1.56 Million
Q2 2023 Aug 14, 2023	BUY	$4.89 - $10.57 $238,372 - $515,255	48,747 Added 120.33%	89,258 $886,000
Q1 2023 May 15, 2023	SELL	$5.62 - $11.51 $80,422 - $164,708	-14,310 Reduced 26.1%	40,511 $234,000
Q4 2022 Feb 14, 2023	SELL	$2.32 - $10.97 $38,407 - $181,608	-16,555 Reduced 23.19%	54,821 $435,000
Q3 2022 Nov 14, 2022	SELL	$3.09 - $9.21 $2,657 - $7,920	-860 Reduced 1.19%	71,376 $226,000
Q2 2022 Aug 15, 2022	SELL	$5.7 - $10.33 $45,126 - $81,782	-7,917 Reduced 9.88%	72,236 $414,000
Q1 2022 May 16, 2022	BUY	$4.41 - $22.5 $160,515 - $818,955	36,398 Added 83.19%	80,153 $1.2 Million
Q4 2021 Feb 14, 2022	SELL	$21.07 - $34.98 $45,637 - $75,766	-2,166 Reduced 4.72%	43,755 $935,000
Q3 2021 Nov 12, 2021	BUY	$24.85 - $40.25 $1.14 Million - $1.85 Million	45,921 New	45,921 $1.36 Million

1.37M

Ticker ICVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,885,200
Description
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.